Qi-Hai Gong Selected Research

Insulin Resistance

1/2022

Trilobatin, a Natural Food Additive, Exerts Anti-Type 2 Diabetes Effect Mediated by Nrf2/ARE and IRS-1/GLUT2 Signaling Pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qi-Hai Gong Research Topics

Disease

10	Alzheimer Disease (Alzheimer's Disease) 10/2022 - 01/2010
6	Cognitive Dysfunction 10/2022 - 07/2010
3	Neuroinflammatory Diseases 10/2022 - 01/2011
3	Hypertrophy 01/2022 - 05/2018
3	Inflammation (Inflammations) 02/2020 - 05/2012
3	Hyperplasia 01/2020 - 01/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2020
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 11/2015 - 01/2011
2	Atherosclerosis 04/2015 - 05/2012
2	Parkinson Disease (Parkinson's Disease) 01/2011 - 12/2008
2	Memory Disorders (Memory Loss) 09/2010 - 08/2007
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Insulin Resistance 01/2022
1	Brain Ischemia (Cerebral Ischemia) 12/2020
1	Laryngeal Neoplasms (Laryngeal Cancer) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Medulloblastoma 01/2020
1	Neoplasms (Cancer) 01/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020
1	Dizziness (Lightheadedness) 01/2018
1	Epilepsy (Aura) 01/2018
1	Dementia (Dementias) 01/2018
1	Ischemic Stroke 01/2018
1	Erectile Dysfunction 06/2014
1	Fibrosis (Cirrhosis) 01/2013
1	Myocardial Infarction 01/2013
1	Obesity 05/2012
1	Cardiomegaly (Heart Hypertrophy) 01/2011
1	Vascular Diseases (Vascular Disease) 01/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2011
1	Neointima 01/2011

Drug/Important Bio-Agent (IBA)

4	Atrial Natriuretic Factor (ANF)IBA 01/2022 - 08/2008
4	Amyloid (Amyloid Fibrils)IBA 02/2020 - 01/2011
4	icariinIBA 11/2015 - 08/2007
3	Angiotensin IIIBA 01/2022 - 01/2013
3	LipopolysaccharidesIBA 02/2020 - 07/2010
3	GinsenosidesIBA 01/2020 - 08/2008
3	Amyloid beta-PeptidesIBA 01/2018 - 01/2010
3	Peptides (Polypeptides)IBA 04/2017 - 01/2010
2	trilobatinIBA 10/2022 - 01/2022
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 04/2019
2	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2022 - 06/2014
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2022 - 08/2008
2	ferulic acid (sodium ferulate)IBA 01/2022 - 04/2019
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2018
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 06/2014
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2020
2	baohuoside IIBA 12/2020 - 02/2020
2	Messenger RNA (mRNA)IBA 05/2018 - 08/2008
2	sodium bisulfide (NaHS)IBA 10/2016 - 07/2010
2	AntioxidantsIBA 04/2015 - 01/2011
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 08/2014 - 09/2010
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 11/2011 - 01/2011
2	Neuroprotective AgentsIBA 01/2011 - 12/2008
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2011 - 07/2010
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2011 - 08/2008
1	Sirtuin 3IBA 10/2022
1	HMGB1 Protein (HMG1)IBA 10/2022
1	Epirubicin (Ellence)FDA LinkGeneric 01/2022
1	Protein Kinase CIBA 01/2022
1	cepharanthineIBA 01/2022
1	Adenosine Monophosphate (AMP)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2022
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Actin Depolymerizing Factors (Cofilins)IBA 01/2022
1	Gemcitabine FDA Link 01/2021
1	Cyclin D1IBA 01/2020
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2020
1	osthol (osthole)IBA 01/2020
1	coumarinIBA 01/2020
1	syringinIBA 01/2020
1	CyclinsIBA 01/2020
1	Cantharidin (Cantharides)IBA 01/2020
1	evodiamineIBA 05/2018
1	CalciumIBA 05/2018
1	gastrodinIBA 01/2018
1	FlavonoidsIBA 11/2015
1	Pharmaceutical PreparationsIBA 11/2015
1	Isoflurane FDA LinkGeneric 08/2014
1	Phosphodiesterase 5 InhibitorsIBA 06/2014
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 06/2014
1	Therapeutic UsesIBA 06/2014
1	leonurineIBA 01/2013
1	PPAR gammaIBA 05/2012
1	ginsenoside Rg1IBA 11/2011
1	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 11/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2011
1	Cysteine (L-Cysteine)FDA Link 02/2011
1	CytokinesIBA 02/2011
1	Amino Acids FDA Link 02/2011
1	Galactose (Galactopyranose)FDA LinkGeneric 09/2010

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2020
1	Percutaneous Coronary Intervention 01/2020
1	Anesthesia 08/2014
1	Intraperitoneal Injections 02/2011